TenAces Biosciences Overview
TenAces Biosciences is a biopharmaceutical company focused on the development of molecular glue therapeutics. The molecular glues are small molecules that can induce or stabilize the interaction between an E3 ligase and a target protein. This enhanced binding accelerates the tagging with ubiquitin, and subsequent removal of the target protein by the proteasome. The company's approach, based on machine learning, 3D modeling and virtual compound screening, allows for the development of rationally designed molecular glues for a wide range of diseases.
Cumulative Funding Raised Over Time ($)
Latest News
growth-positive
AION Labs Launches New Startup Leveraging Machine Learning for Molecular Glue Discovery
AION Labs, a venture studio comprising several pharmaceutical and tech companies, has announced the formation of TenAces Biosciences. The startup is developing a novel approach to discover new molecular glue therapies using machine learning. The platform is expected to facilitate the discovery and development of molecular glue therapies for enhanced targeted protein degradation. TenAces emerged from AION Labs fifth startup challenge to develop an AI platform to identify naturally occurring protein interactions leading to targeted protein degradation.
PartnersInvestment
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Seed |
| Rounds | 1 |
| Investors | 2 |
Team Members
2
Employees: 1-10
Web & Social Links
Locations
Rehovot, Israel
Photos & Videos
No files yet
